These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20135286)

  • 1. Methods for studying activation of matrix metalloproteinases.
    Knäuper V; Murphy G
    Methods Mol Biol; 2010; 622():233-43. PubMed ID: 20135286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
    Stack MS; Itoh Y; Young TN; Nagase H
    Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for studying activation of matrix metalloproteinases.
    Knäuper V; Murphy G
    Methods Mol Biol; 2001; 151():377-87. PubMed ID: 11217313
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
    Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G
    Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of matrix metalloproteinases against matrix substrates.
    Cawston TE; Lakey RL; Rowan AD
    Methods Mol Biol; 2010; 622():245-55. PubMed ID: 20135287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of membrane-type MMPs.
    Nie J; Pei D
    Methods Mol Biol; 2010; 622():99-110. PubMed ID: 20135278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of matrix metalloproteinases against matrix substrates.
    Cawston TE; Koshy P; Rowan AD
    Methods Mol Biol; 2001; 151():389-97. PubMed ID: 11217314
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
    Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
    Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
    Rao CN; Mohanam S; Puppala A; Rao JS
    Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
    Ogata Y; Itoh Y; Nagase H
    J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
    Sato H; Okada Y; Seiki M
    Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
    Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
    Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane independent activation of fibroblast proMMP-2 by snake venom: novel roles for venom proteinases.
    Saravia-Otten P; Frisan T; Thelestam M; Gutiérrez JM
    Toxicon; 2004 Dec; 44(7):749-64. PubMed ID: 15500851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J; Pei D
    Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.